Skip to main content
. 2017 Aug 7;57(5):601–611. doi: 10.1007/s40262-017-0579-4

Fig. 2.

Fig. 2

a Observed vs. individual predicted concentrations, b observed vs. population predicted concentrations, c conditional weighted residuals (CWRES) vs. population predicted concentrations and d CWRES vs. time of the final pharmacokinetic midazolam model for 19 obese adolescents (grey dots) and 20 morbidly obese adults (black dots)